01 1Ajinomoto Omnichem
02 1American Pacific Corporation
03 1Curia New York, Inc.
01 1Brigatinib
02 1brigatinib
03 1not applicable
01 1Japan
02 2U.S.A
NDC Package Code : 50923-1218
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50683-0420
Start Marketing Date : 2016-12-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65392-3311
Start Marketing Date : 2018-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
A Brigatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brigatinib, including repackagers and relabelers. The FDA regulates Brigatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brigatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Brigatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Brigatinib supplier is an individual or a company that provides Brigatinib active pharmaceutical ingredient (API) or Brigatinib finished formulations upon request. The Brigatinib suppliers may include Brigatinib API manufacturers, exporters, distributors and traders.
click here to find a list of Brigatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Brigatinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Brigatinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Brigatinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Brigatinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Brigatinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Brigatinib suppliers with NDC on PharmaCompass.
We have 3 companies offering Brigatinib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
